Study Adds to Research Showing Involuntary Psychiatric Hospitalization Does More Harm Than Good

Posted on July 24, 2023 by cchrstl

NEWS PROVIDED BY

Citizens Commission on Human Rights, National Affairs Office

WASHINGTON, DC, July 13, 2023 — A new study has found that involuntary hospitalization for substance abuse treatment is not effective, adding to the growing body of research finding that forced behavioral health treatment does more harm than good and raising ethical questions about the use of coercion by the psychiatrists typically in charge of the treatment.

Researchers from Harvard Medical School and Brigham and Women’s Hospital in Boston investigated the outcomes of 22 patients involuntarily committed for substance abuse treatment after first coming to a hospital emergency room. The result was that after release, none of the patients stayed off their alcohol and/or drugs, and all of them ended up back in the emergency room within a year because of their substance misuse.

“One year following involuntary commitment, all patients had relapsed to substance use and had at least one emergency department visit,” wrote lead author John C. Messinger. Half reverted to substance abuse within two months after the start of their involuntary treatment.

“The study adds to a growing literature recognizing the harms of involuntary commitment for substance use disorder,” the researchers concluded.

Other research has found that forced hospitalization is also ineffective and harmful for mental health treatment. A study earlier this year found no benefit to patients’ mental health condition and no lower risk of death from nonconsensual mental health treatment.

This follows a 2020 study which found that psychiatric in-patients were actually more likely to attempt suicide after release if they were admitted and treated against their will as compared to those who were not.

The harm and lack of benefit from involuntary commitment for psychiatric treatment has resulted in some people avoiding mental health treatment. The U.S. 2011-2019 National Survey on Drug Use and Health revealed that one in four depressed young adults cited their concern over being involuntarily committed to a psychiatric facility or forced to take psychiatric drugs against their will as a reason not to seek mental health treatment.

The potential of involuntary psychiatric hospitalization and treatment doing more harm than good has led some medical professionals to argue that such acts violate the Hippocratic oath of “first do no harm” and should be abolished.

Among them is the co-founder of the Citizens Commission on Human Rights (CCHR), the late professor of psychiatry and humanitarian Thomas Szasz, M.D., who advocated an end to forced psychiatric treatment. Considered by many scholars and academics to be psychiatry’s most authoritative critic, Dr. Szasz wrote: “Increasing numbers of persons, both in the mental health professions and in public life, have come to acknowledge that involuntary psychiatric interventions are methods of social control. On both moral and practical grounds, I advocate the abolition of all involuntary psychiatry.”

The World Health Organization (WHO) has also taken a strong position against coercive mental health practices. In a series of guidelines issued in 2021, WHO stated that nonconsensual practices are used “despite the lack of evidence that they offer any benefits, and the significant evidence that they lead to physical and psychological harm and even death.”

The guidelines further state: “People subjected to coercive practices report feelings of dehumanization, disempowerment and being disrespected. Many experience it as a form of trauma or re-traumatization leading to a worsening of their condition and increased experiences of distress.”

WHO’s call for an end to involuntary mental health treatment extends even to those experiencing acute mental distress. The guidelines note that individuals in mental health crisis “are at a heightened risk of their human rights being violated, including through forced admissions and treatment.”

WHO challenged United Nations member nations, including the United States, to ensure that their mental health services are free from coercion, including forced drugging, the use of physical and chemical restraints and seclusion, electroshock without consent, and involuntary institutionalization.

The Citizens Commission on Human Rights has been a global leader in the fight against the coercive and abusive use of involuntary commitments, seclusion and restraints, psychiatric drugs, and electroshock. In 1969, CCHR issued a Mental Health Declaration of Human Rights that laid out fundamental human rights in the field of mental health to ensure the right to one’s own mind and the right to be free from forced mental health treatment.

CCHR was co-founded in 1969 by members of the Church of Scientology and Dr. Szasz to eradicate abuses and restore human rights and dignity to the field of mental health. CCHR has been instrumental in obtaining 228 laws against psychiatric abuse and violations of human rights worldwide.

The CCHR National Affairs Office in Washington, DC, has advocated for mental health rights and protections at the state and federal level. The CCHR traveling exhibit, which has toured 441 major cities worldwide and educated over 800,000 people on the history to the present day of abusive and racist psychiatric practices, has been displayed at the Congressional Black Caucus Foundation Annual Legislative Conference in Washington, DC, and at other locations.

Anne Goedeke
Citizens Commission on Human Rights, National Affairs Office

Posted in Big Muddy River Newsletter | Tagged , , , , , , , , | Comments Off on Study Adds to Research Showing Involuntary Psychiatric Hospitalization Does More Harm Than Good

Devastating Movement Disorders Caused by Antipsychotic Drugs Not Listed for Discussion at Psychiatrists’ Annual Meeting

Posted on July 17, 2023 by cchrstl

NEWS PROVIDED BY

Citizens Commission on Human Rights, National Affairs Office

WASHINGTON, DC, July 4, 2023 — None of the hundreds of meetings and sessions offered at the annual conference of the American Psychiatric Association in May was dedicated to discussing the potentially disabling and irreversible movement disorders, including tardive dyskinesia and akathisia, caused by the antipsychotic drugs the psychiatrists prescribe.

Tardive dyskinesia (TD) refers to the drug-induced, involuntary muscle movements that can develop over time from taking antipsychotic drugs, the class of drugs typically prescribed for symptoms of psychosis, mania, anxiety and depression. TD has also been linked to other classes of psychiatric drugs, including antidepressants, mood stabilizers and stimulants.

This psychiatric drug-induced physical disorder is characterized by repetitive, involuntary muscle movements of the face, lips, tongue, limbs, and torso that can range from a slight tremor, unnoticed by the patient, to uncontrollable movements of the entire body. More severe involuntary movements can become a disabling condition and can cause such embarrassment that the individual withdraws from social interaction.

“Tardive dyskinesia is a dreadful disorder caused by all the antipsychotic drugs,” according to psychiatrist Peter Breggin, MD. “People who suffer from it tend to become isolated from society and many become disabled.”

Currently, over 11 million Americans are taking antipsychotics, including more than 800,000 children and teens under the age of 18.

Studies have found that TD will eventually develop in 20%-30% of those taking antipsychotic drugs. Older age is a major risk factor for TD, with up to 50% to 60% of those over the age of 45 ultimately developing the movement disorder. This prevalence suggests that several million Americans may already be experiencing the symptoms of TD.

Race is also a risk factor for TD. A 2004 evaluation found antipsychotic-induced TD is more prevalent in African Americans than Americans of European descent.  This finding is even more consequential in light of the fact that African Americans are disproportionately diagnosed with psychosis and schizophrenia and then are likely to be prescribed antipsychotic drugs.

Even after discontinuing the drugs, TD may persist for years in a majority of patients who develop the condition, and it is often  permanent. A 2014 study at Emory University’s movement disorders clinic found that only about one in eight patients ever fully recover from TD.

Many taking antipsychotic drugs report they were not told of the risk of tardive dyskinesia by their doctor. A 2019 survey found that 58% of patients were not aware that the antipsychotics they were taking could cause TD. Among those suffering TD symptoms, 80% were emotionally distressed by their jerky movements, nearly half (47%) said it affected their job performance, and two-thirds reported a drop in self-esteem (68%) and self-confidence (64%).

Antipsychotics can also cause akathisia, a movement disorder characterized by restlessness and an inability to sit still. According to medical researcher Peter Gøtzsche, MD, “akathisia is one of the most dangerous harms of [antipsychotics] and depression drugs, as it predisposes [patients] to suicide, violence and homicide.” He says that psychiatrists typically misinterpret akathisia’s symptom of restless behavior as the patient’s need for a higher dose of the antipsychotics, which only worsens the situation.

One study found that half of all fights in a psychiatric ward stemmed from the akathisia related to the antipsychotic drugs the patients were taking, while another study revealed that 79% of mentally ill patients who attempted suicide suffered from the agitation of akathisia.

The continued prescribing of potentially disabling antipsychotic drugs is being further enabled by highly profitable drugs that were developed to treat TD, which patients take while they continue to stay on the antipsychotic or other drugs that are causing their TD. Drug companies manufacturing TD treatments have predicted sales of $1 billion to $2 billion per year. The TD-treatment drugs come with their own side effects, ironically including akathisia and agitation, as well as depression and suicidality.

The Citizens Commission on Human Rights (CCHR) continues to raise public awareness of the risks of serious side effects and withdrawal symptoms from antipsychotics and other psychiatric drugs, so that consumers and their physicians can make fully informed decisions about starting or stopping the drugs.

CCHR recommends a complete physical examination with lab tests, nutritional and allergy screenings, and a review of all current medications to identify any physical causes of unwanted mental or behavioral symptoms, which might otherwise be misdiagnosed as a psychiatric disorder and incorrectly treated.

WARNING: Anyone wishing to discontinue or change the dose of a psychiatric drug is cautioned to do so only under the supervision of a physician because of potentially dangerous withdrawal symptoms.

The Citizens Commission on Human Rights was co-founded in 1969 by members of the Church of Scientology and the late psychiatrist and humanitarian Thomas Szasz, M.D., recognized by many academics as modern psychiatry’s most authoritative critic, to eradicate abuses and restore human rights and dignity to the field of mental health. CCHR has been instrumental in obtaining 228 laws against psychiatric abuse and violations of human rights worldwide.

The CCHR National Affairs Office in Washington, DC, has advocated for mental health rights and protections at the state and federal level. The CCHR traveling exhibit, which has toured 441 major cities worldwide and educated over 800,000 people on the history to the present day of abusive and racist psychiatric practices, has been displayed at the Congressional Black Caucus Foundation Annual Legislative Conference in Washington, DC, and at other locations.

Anne Goedeke
Citizens Commission on Human Rights, National Affairs Office

Posted in Big Muddy River Newsletter | Tagged , , , , , , | Comments Off on Devastating Movement Disorders Caused by Antipsychotic Drugs Not Listed for Discussion at Psychiatrists’ Annual Meeting

Many Common Psychiatric Drugs Can Increase Patients’ Risk of Heat-Related Illness

Posted on July 10, 2023 by cchrstl

NEWS PROVIDED BY

Citizens Commission on Human Rights, National Affairs Office

WASHINGTON, DC, June 28, 2023/EINPresswire.com/ — Extreme heat, like the heat wave currently gripping the U.S. South, is especially dangerous for those prescribed many common psychiatric drugs, particularly antipsychotic drugs, that increase the risk of heat-related illness, ranging from the mild discomfort of heat cramps to the more serious symptoms of heat exhaustion and life-threatening heat stroke.

Many common psychiatric drugs can impair the body’s cooling mechanism or cause the people taking them to be less sensitive to signs of overheating, thus predisposing them to heat-related illness. Medical emergencies occur when the body’s temperature rises to dangerous levels and the body becomes unable to lower its temperature. Bodily damage, which can be fatal, occurs if steps are not taken to lower body temperature. One study found that taking psychiatric drugs nearly doubled the risk of death during a heat wave.

The elderly are even more susceptible to the risk of heat-related illness. The body’s temperature regulation is generally slower in older adults. Compared to young people, older adults also sweat less and radiate less heat, so the core body temperature rises more easily. The rate of hospitalization for heat stroke is significantly higher for older adults and their hospital stays are longer.

“In special risk situations such as heat waves, the risk/benefit ratio of psychotropic drugs which could interfere with body temperature regulation has to be carefully assessed, particularly in the elderly,” concluded French researchers, led by Karin Martin-Latry, PharmD, PhD, in a study published in European Psychiatry.

How many people taking psychiatric drugs end up with heat-related medical emergencies? Nobody knows.

“Due to the lack of research in the field, it is impossible to estimate the scale of the problem” of the interaction between drugs and heat, Ying Zhang, senior lecturer at the University of Sydney’s School of Public Health, told the Washington Post.

During periods of extreme heat, those taking antipsychotic drugs are at particular risk of heat stroke. Antipsychotics reduce sweating, the body’s natural means of cooling, as well as reduce the users’ behavior to cool themselves, like drinking more water or removing extra clothing. Even a short time in very hot weather can cause a rapid rise in body temperature for people on these drugs.

“Patients who are prescribed antipsychotics should be aware of the potentially fatal adverse events that can occur from these medications,” warned doctors in a recently published case report on antipsychotic drug-induced hyperthermia.

Stimulant drugs, like ADHD drugs, are known to raise body temperature, as well as interfere with the body’s ability to cool itself down. High summer temperatures can cause body temperatures that are already elevated by these drugs to go higher still.

Tricyclic antidepressants decrease sweating, along with inhibiting the body’s ability to regulate temperature, which can result in body temperature rising to dangerous levels during summer heat waves.

Selective serotonin reuptake inhibitor (SSRI) antidepressants can increase sweating while at the same time reducing thirst, which can lead to dehydration and heat illness in very hot weather.

Those taking psychiatric drugs should limit their exposure to summer heat and strenuous activity and drink plenty of water. Seek immediate medical attention for anyone showing signs of heat stroke, including confusion, unconsciousness, a rapid pulse, a high temperature, or red, hot, dry skin.

The Citizens Commission on Human Rights (CCHR) continues to raise public awareness of the risks of serious side effects from psychiatric drugs, so that consumers and their physicians can make fully informed decisions about starting or stopping the drugs.

CCHR recommends a complete physical examination with lab tests, nutritional and allergy screenings, and a review of all current medications to identify any physical causes of unwanted mental or behavioral symptoms, which might otherwise be misdiagnosed as a psychiatric disorder and incorrectly treated.

WARNING: Anyone wishing to discontinue or change the dose of a psychiatric drug is cautioned to do so only under the supervision of a physician because of potentially dangerous withdrawal symptoms.

The Citizens Commission on Human Rights was co-founded in 1969 by members of the Church of Scientology and the late psychiatrist and humanitarian Thomas Szasz, M.D., recognized by many academics as modern psychiatry’s most authoritative critic, to eradicate abuses and restore human rights and dignity to the field of mental health. CCHR has been instrumental in obtaining 228 laws against psychiatric abuse and violations of human rights worldwide.

The CCHR National Affairs Office in Washington, DC, has advocated for mental health rights and protections at the state and federal level. The CCHR traveling exhibit, which has toured 441 major cities worldwide and educated over 800,000 people on the history to the present day of abusive and racist psychiatric practices, has been displayed at the Congressional Black Caucus Foundation Annual Legislative Conference in Washington, DC, and at other locations.

Anne Goedeke
Citizens Commission on Human Rights, National Affairs Office

Posted in Big Muddy River Newsletter | Tagged , , , , , , | Comments Off on Many Common Psychiatric Drugs Can Increase Patients’ Risk of Heat-Related Illness

White Paper on Improving Psychiatric Patient Outcomes

Posted on July 3, 2023 by cchrstl

Reference:
WHITE PAPER on Improving Patient Outcomes, Addressing Treatment Caused Trauma & Injuries, Enhancing Patient Rights, and Grievance Procedures for the Report Required by § 36 of CH 41 SLA 2022 (HB172)
by James B. (Jim) Gottstein, Esq.; Faith Myers; Susan Musante, LPCC; David Cohen, PhD; Peter C. Gøtzsche, MD; David Healy, MD; The International Society for Ethical Psychology & Psychiatry
April 2023, Addenda May 2023
Anchorage, Alaska

[Note: Full references and citations are provided in the original White Paper.]

On July 15, 2022, Alaska Governor Mike Dunleavy signed HB172 into law which requires the Department of Health, Department of Family and Community Services, and the Alaska Mental Health Trust Authority to report on, among other things, improving psychiatric patient outcomes, institutional trauma, enhancing patient rights, the grievance process, and patient injuries.

The Legislation was enacted to comply with a settlement over a successful lawsuit brought against the State of Alaska for illegally confining people for extended periods of time in correctional facilities and emergency rooms awaiting admission to the Alaska Psychiatric Institute for court ordered psychiatric evaluations.

This White Paper provides input for the required Report to the Legislature, focusing on improving patient outcomes, enhancing patient rights, having an effective and legitimate grievance process, and addressing patient injuries and treatment-caused trauma.

Executive Summary of the White Paper

If the fundamental purpose of the mental health system is to improve the lives of psychiatric patients it is failing miserably. That the State does not keep track of institutional trauma and patient complaints, and has no legitimate grievance process are illustrations of the lack of commitment to improving patients’ lives.

The mental health system’s standard treatments are counterproductive and harmful, and often forced on unwilling patients. The overreliance on psychiatric drugs is reducing the recovery rate of people diagnosed with serious mental illness and reducing their life spans. Psychiatric incarceration, euphemistically called “involuntary commitment,” is similarly counterproductive and harmful, adding to patients’ trauma and massively associated with suicides. Harmful psychiatric interventions are being imposed on people by judges in proceedings where the facts about treatments and their harms are not being presented by appointed counsel, rendering the proceedings shams.

Court proceedings to psychiatrically incarcerate people on the grounds it is necessary to protect other people from harm should be eliminated; predictions of violence are not accurate and no one else besides someone who receives a psychiatric diagnosis is incarcerated for something they might do in the future. Court proceedings to psychiatrically drug people against their will on the grounds it is in their best interest should be eliminated. They are not in people’s best interest if unwanted. “If it is not voluntary it is not treatment.” If such proceedings are nonetheless held, they should be conducted in a legitimate manner.

The most important elements for improving patients’ lives are People, Place and Purpose. People—even psychiatric patients—need to have a safe place to live (Place), relationships (People), and to have activity that is meaningful to them, usually school or work (Purpose). People need to be given hope these are possible. Voluntary approaches that improve people’s lives should be made available instead of the currently prevailing counterproductive and harmful psychiatric drugs for everyone, forever regime often forced on people. The White Paper lists at least 8 successful non-drug treatment programs that already exist for people experiencing mental distress. Brutal incarceration and coercive psychiatry is not the only option.

By implementing these approaches, Alaska’s mental health system can improve the recovery rate. As bad as it is for adults, the psychiatric incarceration and psychiatric drugging of children and youth is even more tragic and should be stopped. Instead, children and youth should be helped to manage their emotions and become successful, and their parents should be given support and assistance to achieve this.

Posted in Big Muddy River Newsletter | Tagged , , , , , , , , | Comments Off on White Paper on Improving Psychiatric Patient Outcomes

Psychiatrists at Annual Conference Warned That Antidepressants They Prescribe Can Deaden Patients’ Emotions

Posted on June 26, 2023 by cchrstl

New study confirms patients’ common complaints of antidepressants deadening their emotions and harming their sex life.

NEWS PROVIDED BY

Citizens Commission on Human Rights, National Affairs Office

WASHINGTON, DC, June 15, 2023 — A new study presented at the annual conference of the American Psychiatric Association informed psychiatrists that the emotional blunting caused by the antidepressants they prescribe is a significant and under-recognized side effect patients may suffer.

The current study reviewed 25 prior studies related to the problem of antidepressant-induced emotional blunting, described as “a persistent diminution in both positive and negative feelings,” which the patients differentiated as side effects of the drugs rather than symptoms of their depression.

The researchers concluded that “emotional blunting was a significant patient-reported concern with antidepressants.” That dulling of emotions could also be experienced as a change in personality or as not feeling like oneself.

A separate study earlier this year also found that participants given a selective serotonin reuptake inhibitor (SSRI) antidepressant experienced a reduction in positive emotions, along with a significant increase in sexual problems that the researchers suggested could be due to the reduced emotional pleasure.

Sexual dysfunction is reportedly experienced by many patients on antidepressants. Half of the antidepressant users who responded to a recent survey reported experiencing sexual problems they did not have before taking the drugs – problems that can strain relationships and lead to a worsening of the depression for which the drugs are being prescribed.

These findings add new credibility to patients’ common complaints of antidepressants deadening their emotions and sex life.

Worse still, the sexual disability can persist indefinitely, even after antidepressants are discontinued.  The condition, referred to as post-SSRI sexual dysfunction, has no definitive treatment, a fact many patients were not made aware of by their prescribers before starting antidepressants.

A key rationale for prescribing antidepressants in the first place – to fix a chemical balance in the brain – was recently found to be without scientific merit. Researchers conducted a comprehensive review of the research that had looked into whether a lack of the brain chemical serotonin causes depression and concluded there was no convincing evidence to support the theory.

“The serotonin theory of depression has been one of the most influential and extensively researched biological theories of the origins of depression,” wrote the study’s lead author, Joanne Moncrieff. “Our study shows that this view is not supported by scientific evidence. It also calls into question the basis for the use of antidepressants.”

Also challenging the prescribing of antidepressants are the results of a study which found that taking antidepressants led to worse depression symptoms for patients years later. Patients who used antidepressants at any time during the 30-year period of the study had an 81% greater chance of experiencing more severe depression symptoms at the end of the period.

The Citizens Commission on Human Rights (CCHR) continues to raise public awareness of the risks of serious side effects and withdrawal symptoms from antidepressants and other psychiatric drugs, so that consumers and their physicians can make fully informed decisions about starting or stopping the drugs.

CCHR also recommends a complete physical examination with lab tests, nutritional and allergy screenings, and a review of all current medications to identify any physical causes of depression or other unwanted mental and emotional symptoms, which might otherwise be misdiagnosed and incorrectly treated as a psychiatric disorder.

WARNING: Anyone wishing to discontinue or change the dose of an antidepressant or other psychiatric drug is cautioned to do so only under the supervision of a physician because of potentially dangerous withdrawal symptoms.

The Citizens Commission on Human Rights was co-founded in 1969 by members of the Church of Scientology and the late psychiatrist and humanitarian Thomas Szasz, M.D., recognized by many academics as modern psychiatry’s most authoritative critic, to eradicate abuses and restore human rights and dignity to the field of mental health. CCHR has been instrumental in obtaining 228 laws against psychiatric abuses and violations of human rights worldwide.

The CCHR National Affairs Office in Washington, DC, has advocated for mental health rights and protections at the state and federal level. The CCHR traveling exhibit, which has toured 441 major cities worldwide and educated over 800,000 people on the history to the present day of abusive and racist psychiatric practices, has been displayed at the Congressional Black Caucus Foundation Annual Legislative Conference in Washington, DC, and at other locations.

Anne Goedeke
Citizens Commission on Human Rights, National Affairs Office
202-349-9267

Posted in Big Muddy River Newsletter | Tagged , , , , , | Comments Off on Psychiatrists at Annual Conference Warned That Antidepressants They Prescribe Can Deaden Patients’ Emotions

PTSD Awareness Month

Posted on June 19, 2023 by cchrstl

Psychiatric Drugs Prescribed for PTSD Linked to Stubbornly High Rates of Veteran Suicides

NEWS PROVIDED BY

Citizens Commission on Human Rights, National Affairs Office

WASHINGTON, DC, June 8, 2023/ — During PTSD Awareness Month, attention turns to the aftermath of traumatic events, which have always been part of the human experience. But so-called post-traumatic stress disorder is being applied more broadly these days to a wide range of stressful events, turning them into psychiatric disorders for which the prescription is typically mind-altering psychotropic drugs – drugs which carry the risk of suicidal thoughts and actions. This risk is especially relevant to former service members, in light of the stubbornly high rates of veteran suicides.

The rate of suicides by former service members is a matter of some debate. The 2022 National Veteran Suicide Prevention Annual Report, issued by the U.S. Department of Veterans Affairs (VA), reported an average of 17 veteran suicides per day during 2020, the most recent year for which national death certificate data is available. The rate of veteran suicides per 100,000 population was 57% higher than the rate of non-veteran adult suicides.

The VA’s suicide rate per day has been challenged in a study underway by a veteran suicide prevention organization, America’s Warrior Partnership, which is using state mortality data gathered by the University of Alabama and analyzed at Duke University in coordination with the U.S. Department of Defense (DOD). So far, five years of death data from eight states has been analyzed, with corrections made to the states’ data reporting. An interim report on the study says that if these eight states are representative of the rest of the nation, the veteran suicide rate would be at least 44 per day, which is 2.4 times higher than the VA’s reported rate.

Whatever the rate, it is completely unacceptable. The VA further reported that 40% of the suicides were committed by veterans who had used the VA health care system in the year prior to their death. This reflects a 43% increase in suicides by VA health services users since 2005.

What accounts for this continuing high number of suicides, especially among veterans who utilized VA health services?

In response to a Freedom of Information Act (FOIA) request filed in 2021 by the Citizens Commission on Human Rights International (CCHR), the Veterans Health Administration revealed that in 2019, 4.2 million veterans were taking psychiatric drugs, including antidepressants, antipsychotic drugs, antianxiety drugs, and mood stabilizers. These drugs have the known side effects of suicidal thoughts, suicide attempts, and completed suicides – adverse events reported to the U.S. Food and Drug Administration (FDA) in drug studies and by consumers.

Of the 4.2 million former service members prescribed psychiatric drugs, 1.75 million (41%) of them were prescribed antidepressants, which is typical treatment for PTSD, as well as depression. The VA website’s information on PTSD lists antidepressants as the only medications for treatment.

The FDA has required a black box warning, its most stringent warning, on antidepressant labels to alert users to the increased risk of suicidal thoughts and actions in those under the age of 25, an age range that includes many of active service members and veterans who have taken their own lives.

CCHR has long advocated for the warning to be expanded to include all adults, based on empirical evidence. Researchers who conducted a systematic review and meta-analysis of clinical trials in which SSRI and SNRI antidepressants were given to healthy adult volunteers with no signs of depression found that antidepressants double the risk of suicidality and violence.

Another study re-analyzed data submitted to the FDA for approval of antidepressants and found that the rate of suicide attempts in drug trials was about 2.5 times higher in patients using antidepressants as compared to those taking placebos.

The prescriptions for psychiatric drugs for military personnel soared from 2005 to 2011, increasing sevenfold over the period, according to the DOD – more than 30 times the rate among the civilian population. Already by 2013, the Military Times reported that one in six American service members was taking at least one psychiatric drug. At the same time, military suicides were rising dramatically.

And the suicides continue. Brown University’s Costs of War Project reported that an estimated 30,177 active-duty service members and war veterans of the post 9/11 wars have died by suicide, more than four times as many as the 7,057 killed in military operations. “The suicide rate of veterans overall and adjusted for age and sex is 1.5 times that of the general population,” according to the report. “Moreover, the current suicide rate of 45.9 [per 100,000 population] among veterans [ages] 18-34 is about 2.5 times the suicide rate of that of the adjusted general population (18 per 100,000).”

To address the risks of psychiatric drugs as mental health treatment given to our active-duty military and veterans, CCHR produced its acclaimed documentary, Hidden Enemy: Inside Psychiatry’s Covert Agenda. It features interviews with more than 80 experts, soldiers, and veterans and presents evidence linking the rising number of psychiatric drug prescriptions with military suicides and sudden deaths.

The Citizens Commission on Human Rights continues to raise public awareness of the risks of serious side effects and withdrawal symptoms from antidepressants and other psychiatric drugs, so that consumers and their physicians can make fully informed decisions about starting or stopping the drugs. CCHR supports safe and science-based non-drug approaches to mental health.

CCHR recommends a complete physical examination with lab tests, nutritional and allergy screenings, and a review of all current medications to identify any physical causes of depression or other unwanted mental and emotional symptoms, which might otherwise be misdiagnosed as a psychiatric disorder and incorrectly treated.

WARNING: Anyone wishing to discontinue or change the dose of a psychiatric drug is cautioned to do so only under the supervision of a physician because of potentially dangerous withdrawal symptoms.

The Citizens Commission on Human Rights was co-founded in 1969 by members of the Church of Scientology and the late psychiatrist and humanitarian Thomas Szasz, M.D., recognized by many academics as modern psychiatry’s most authoritative critic, to eradicate abuses and restore human rights and dignity to the field of mental health. CCHR has been instrumental in obtaining 228 laws against psychiatric abuse and violations of human rights worldwide.

The CCHR National Affairs Office in Washington, DC, has advocated for mental health rights and protections at the state and federal level. The CCHR traveling exhibit, which has toured 441 major cities worldwide and educated over 800,000 people on the history to the present day of abusive and racist psychiatric practices, has been displayed at the Congressional Black Caucus Foundation Annual Legislative Conference in Washington, DC, and at other locations.

Anne Goedeke
Citizens Commission on Human Rights, National Affairs Office

Posted in Big Muddy River Newsletter | Tagged | Comments Off on PTSD Awareness Month

Primary Care Doctors Advised Not to Prescribe Antidepressants to Patients on First Visit for Mild to Moderate Depression

Posted on June 5, 2023 by cchrstl

NEWS PROVIDED BY

Citizens Commission on Human Rights, National Affairs Office

WASHINGTON, DC, May 25, 2023 — Researchers are advising primary care doctors not to prescribe antidepressants to patients with mild to moderate depression on their first visit because of the drugs’ limited effectiveness and risks of significant side effects. Their conclusion, based on reviews of the available evidence on antidepressants, was published in World Psychiatry, the journal of the World Psychiatric Association.

Noting that most depressed patients in primary care settings have mild to moderate depression, the researchers cite recent research that found the benefit of antidepressants for such patients is so small that it may not be clinically significant. Instead, the researchers suggest non-drug approaches for these patients.

“Antidepressants should not be prescribed at the first visit if the patient has mild to moderate depression, because they have a limited efficacy and may have significant side effects,” according to lead author Bruce Arroll, professor in the Department of General Practice and Primary Health Care at the University of Auckland in New Zealand.

Even for a first visit to primary care by severely depressed patients, antidepressants may not be the best treatment, the researchers say. “The best strategy may be to reframe some of the negative cognitions of the patients and advise physical activity,” writes Arroll, with follow-up to track the patients’ results.

This advice is similar to guidance issued in 2021 by the organization that develops standards for health care practices in England. The London-based National Institute for Health and Care Excellence advised doctors not to routinely prescribe antidepressants as first-line treatment for people with less severe depression, but to offer a variety of non-drug treatment options and to respect the patients’ right to decline treatment.

Recent studies have found little, if any, benefit to antidepressants over placebos. Researchers led by Marc B. Stone of the FDA’s Center for Drug Evaluation and Research combined the results of 232 randomized controlled trials reported to the FDA from 1979 to 2016 that compared the effect of selective serotonin reuptake inhibitor (SSRI) antidepressants with placebos for patients with depression. Publishing their report in 2022 in the British Medical Journal, the researchers found that a benefit from antidepressants over placebos was limited to just 15% of the patients, while the other 85% experienced no benefit as compared to placebos. The placebo effect was powerful, with roughly two-thirds of the depressed patients given placebos getting better.

Another 2022 study found no clinically significant difference in measures of depression symptoms between adults treated with antidepressants and those taking placebos, whether over a shorter or longer time frame and regardless of the depression severity of the study participants.

Some 45 million Americans are currently taking one or more antidepressants, including 5.7 million children and young adults under the age of 25, for whom the FDA requires a warning on the drug’s prescribing information of the increased risk of suicidal thoughts and actions.

Other adverse effects of antidepressants include weight gain, nausea, insomnia, agitation, emotional blunting and sexual dysfunction. One recent study found that half of antidepressant users experience sexual problems that can strain their relationships and lead to a worsening of their depression.  In a survey of antidepressant users, 44% of respondents reported the drugs negatively impacted their sex lives, 27% their ability to work or study, and 21% their relationships with friends or family.

Those who used antidepressants any time during the 30-year period of another recent study had an 81% greater chance of having more severe depression symptoms at the end of the study.

Antidepressants may be prescribed to prevent suicides, but an examination of coroner inquests in which the decedents used antidepressants revealed that about half of the deaths were determined to be suicides.  One in eight of the deaths involved an overdose of antidepressants.

Discontinuing antidepressants can bring on serious symptoms during withdrawal, including electric shock-like sensations (“brain zaps” and “body zaps”), muscle spasms and tremors, hallucinations, confusion, irritability, and mania. One study found that more than half (56%) of people attempting to come off antidepressants experience withdrawal symptoms, with nearly half (46%) of them describing those symptoms as severe, and the symptoms can last for weeks or months.

More fundamentally, a landmark 2022 study questioned the prescribing of antidepressants at all, after finding the common reason for taking them – to correct a chemical imbalance in the brain – had no scientific basis. The study investigated whether evidence supported the theory that a low level of the brain chemical serotonin causes depression.

“The serotonin theory of depression has been one of the most influential and extensively researched biological theories of the origins of depression,” the researchers wrote. “Our study shows that this view is not supported by scientific evidence. It also calls into question the basis for the use of antidepressants.”

WARNING: Anyone wishing to discontinue or change the dose of an antidepressant or other psychiatric drug is cautioned to do so only under the supervision of a physician because of potentially dangerous withdrawal symptoms.

The Citizens Commission on Human Rights (CCHR) continues to raise public awareness of the risks of serious side effects and withdrawal symptoms from antidepressants and other psychiatric drugs, so that consumers and their physicians can make fully informed decisions about starting or stopping the drugs. CCHR supports safe and science-based non-drug approaches to mental health.

CCHR also recommends a complete physical examination with lab tests, nutritional and allergy screenings, and a review of all current medications to identify any physical causes of depression or other unwanted mental and behavioral symptoms, which might otherwise be misdiagnosed and incorrectly treated as a psychiatric disorder.

The Citizens Commission on Human Rights was co-founded in 1969 by members of the Church of Scientology and the late psychiatrist and humanitarian Thomas Szasz, M.D., recognized by many academics as modern psychiatry’s most authoritative critic, to eradicate abuses and restore human rights and dignity to the field of mental health. CCHR has been instrumental in obtaining 228 laws against psychiatric abuse and violations of human rights worldwide.

The CCHR National Affairs Office in Washington, DC, has advocated for mental health rights and protections at the state and federal level. The CCHR traveling exhibit, which has toured 441 major cities worldwide and educated over 800,000 people on the history to the present day of abusive and racist psychiatric practices, has been displayed at the Congressional Black Caucus Foundation Annual Legislative Conference in Washington, DC, and at other locations.

Anne Goedeke
Citizens Commission on Human Rights, National Affairs Office

1701 20th St. NW

Washington, DC 20009

(202) 349-9267

Posted in Big Muddy River Newsletter | Tagged , , , , , , , | Comments Off on Primary Care Doctors Advised Not to Prescribe Antidepressants to Patients on First Visit for Mild to Moderate Depression

What Is Your Emotional Intelligence?

Posted on May 31, 2023 by cchrstl

We notice continuing discussions in social media about “emotional intelligence”, although with few successful attempts to actually nail it down.

It used to simply be called “maturity.” Attempts by psychiatry and psychology to dissect it make it more complicated and subject to argument about what it really is. We thought we’d like to weigh in on the discussion, and relate it to psychiatric fraud and abuse.

Some definitions:
[These are not all the possible definitions, but are useful ones.]

Emotional: Relating to a state of feelings or sensations created or experienced by an individual or a body; the physical, mental and spiritual state of an individual manifested as a gradient scale of an individual’s state of being.
[From Latin emov?re to remove, displace, from e– + mov?re to move.]

Intelligence: The ability to perceive, pose and resolve problems; the ability to recognize differences, similarities and identities, and evaluate relative importances.
[From Latin intellegere, to understand.]

Maturity: Relating to a condition of full growth or development; behaving in a sensible way; well-balanced in personality and emotional behavior.
[From Latin maturus, ripe.]

We take the term “Emotional Intelligence” to mean the ability to use one’s emotions intelligently and appropriately in different situations.

Some psychiatrists and psychologists relate emotional intelligence to mental health disorders. Witness the Diagnostic and Statistical Manual of Mental Disorders (DSM) which describes numerous fraudulent diagnoses for which they can prescribe any number of harmful, mind-altering psychiatric drugs. [The purpose of which is to be able to bill insurance for counseling or drugs for any of these diagnoses.] Here are some of those absurd DSM diagnoses:

— Adjustment disorder, With mixed disturbance of emotions and conduct
— High expressed emotion level within family
— Borderline intellectual functioning
— Intellectual disability (intellectual developmental disorder)
— Disinhibited social engagement disorder

This over-complication of an essentially simple concept leads to endless speculation, the wasted funds for hundreds of research papers, and no end of descriptions about its components and what to do about it.

There is one very simple way to learn to be more emotionally intelligent — by learning to identify the emotions one is feeling as well as understanding them. You won’t learn this, however, from a psychiatrist.

Posted in Big Muddy River Newsletter | Tagged , , | Comments Off on What Is Your Emotional Intelligence?

FDA Updates Warning on Stimulants Prescribed for ADHD, Now Lists Risks of Misuse, Addiction, Diversion and Overdose

Posted on May 22, 2023 by cchrstl

NEWS PROVIDED BY

Citizens Commission on Human Rights, National Affairs Office

WASHINGTON, DC, May 18, 2023 — The U.S. Food and Drug Administration (FDA) is requiring new warnings in the prescribing information for stimulant drugs used to treat so-called attention-deficit hyperactivity disorder (ADHD) “to address continuing concerns of misuse, abuse, addiction, and overdose of the prescription drugs,” according to the FDA’s statement on the change. The “boxed warning” being updated is the most prominent warning the FDA can require for drugs.

Stimulants commonly prescribed for ADHD that will now carry the elevated warning include Adderall, Concerta, Dexedrine, and Ritalin. The U.S. Drug Enforcement Agency (DEA) classifies these drugs as Schedule II controlled substances – the same drug classification as for cocaine, morphine, oxycodone, and fentanyl. The DEA warns that use of stimulant drugs can lead to “severe psychological or physical dependence” and that “these drugs are also considered dangerous.” Diversion of the drugs is illegal.

In explaining its reason for the heightened warning, the FDA states, “The current prescribing information for some prescription stimulants does not provide up to date warnings about the harms of misuse and abuse, and particularly that most individuals who misuse prescription stimulants get their drugs from other family members or peers.”

Diversion of prescribed stimulant drugs from patients to others is a longstanding problem, particularly among children and young adults. Research has found that a range of 16% to 29% of students from grade school through college who have stimulant prescriptions are asked to give, sell, or trade their medications.

The FDA’s new warning for stimulants reads, in part: “WARNING: ABUSE, MISUSE, AND ADDICTION. [Name of drug] has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS [central nervous system] stimulants, including [Name of drug], can result in overdose and death.”

The latest figures from the Centers for Disease Control and Prevention (CDC) show that overdose deaths from stimulant drugs have tripled from 10,255 deaths in 2017 to 32,478 in 2022. This increase is occurring in the context of a national overdose crisis, in which stimulants are increasingly involved, according to the CDC.

The FDA’s communication lists some of the serious side effects of stimulant drugs that require emergency treatment, including fast heart rate, fast breathing, increased blood pressure, restlessness, tremors, loss of coordination, nausea and vomiting, aggressive behavior, panic, confusion, and hallucinations. Stimulants are also linked to stunted growth in children.

Some 9.6 million Americans are prescribed stimulant drugs for so-called ADHD. However, there is no objective, scientific basis for “diagnoses” of mental disorders, as acknowledged by Thomas Insel, M.D., former director of the National Institute of Mental Health (NIMH), in his blog on the NIMH website in 2013. This means it is far too easy to “diagnose” ADHD.

The late psychologist Keith Conners conducted the first formal trials on the now-widely prescribed ADHD stimulant methylphenidate, commonly sold under the brand names Ritalin and Concerta. He later realized that ADHD diagnoses were out of control and called ADHD misdiagnoses “a national disaster of dangerous proportions.”

One in three Americans taking ADHD drugs is under the age of 18, but research has raised concerns over prescribing stimulants to children. Beyond the risks of serious adverse effects, a recent study found no convincing evidence of any long-term benefit to children from treatment for ADHD with stimulant drugs.

Another recent study found that children started on ADHD treatment with the stimulant methylphenidate were 18 times more likely to experience depression than before starting, and when the drug was discontinued, the higher risk dropped back to starting levels. [1]

Children who were first prescribed methylphenidate between the ages of 6 and 8 and continued to take the drugs had a 50% higher risk of being prescribed antidepressants for depression during their teen years, another study found. [2]

CCHR continues to raise public awareness of the risks of serious side effects and withdrawal symptoms from psychostimulants and other psychiatric drugs, so consumers and their physicians can make fully informed decisions about starting or stopping the drugs. CCHR supports safe and science-based non-drug approaches to mental health.

WARNING: Anyone wishing to discontinue or change the dose of an ADHD drug or any other psychiatric drug is cautioned to do so only under the supervision of a physician because of potentially dangerous withdrawal symptoms.

The Citizens Commission on Human Rights was co-founded in 1969 by members of the Church of Scientology and the late psychiatrist and humanitarian Thomas Szasz, M.D., recognized by many academics as modern psychiatry’s most authoritative critic, to eradicate abuses and restore human rights and dignity to the field of mental health. CCHR has been instrumental in obtaining 228 laws against psychiatric abuse and violations of human rights worldwide.

The CCHR National Affairs Office in Washington, DC, has advocated for mental health rights and protections at the state and federal level. The CCHR traveling exhibit, which has toured 441 major cities worldwide and educated over 800,000 people on the history to the present day of abusive and racist psychiatric practices, has been displayed at the Congressional Black Caucus Foundation Annual Legislative Conference in Washington, DC, and at other locations.

[1] https://www.cpn.or.kr/journal/view.html?volume=20&number=2&spage=320#B19
[2] https://pubmed.ncbi.nlm.nih.gov/30828744/

Posted in Big Muddy River Newsletter | Tagged , , | Comments Off on FDA Updates Warning on Stimulants Prescribed for ADHD, Now Lists Risks of Misuse, Addiction, Diversion and Overdose

More About Shock Therapy

Posted on May 15, 2023 by cchrstl

The barbaric and shameful psychiatric use of shock treatments unfortunately has a lengthy history. By shock we mean such atrocities as electrotherapy (various methods of shocking body parts with electricity), temperature therapy (shocking with hot or cold temperatures), insulin shock therapy, cardiazol (metrazol) shock therapy (a drug that induces seizures), deep brain stimulation, lobotomy (hacking off connections in the brain), deep sleep (narcosis), and of course the “modern” way of inducing seizures with electroconvulsive therapy (ECT).

The point is that these psychiatric treatments emphasize the aspect of shock.

Fraudulent Psychiatric Diagnosis

There is no evidence of any kind that there is anything called a mental illness as described in the Diagnostic and Statistical Manual of Mental Disorders (DSM). The whole of psychiatry is based on a wrong conclusion. Psychiatry looks only at a person’s stimulus-response behavior, and assumes that is all there is to a human being.

Why Shock Therapy?

Psychiatry resorted to such savage and bestial treatments as these various shock therapies because they were up against people who apparently would not be helped, and they had (and still have) no clue about how to actually help them — about how to gradiently replace stimulus-response behavior with self-determined behavior.

Someone with troubles is already at a lower level of awareness. Pain is then what they are most aware and certain of. The psychiatrist is there to deliver more pain in the mistaken idea that this will cause the insane to be less insane. However, the certainty and awareness of pain which is delivered by the impact of shock is a non-self-determined certainty. Certainty delivered by force, pain, blows and shock eventually brings about only unconsciousness and the certainty of unawareness.

Psychiatry is not particularly interested in increasing awareness; they would rather blunt someone’s awareness by shock in a misguided attempt to make a person less aware of their surroundings, their pain and troubles.

Shock does not and never can cause an improvement in mental health, since it produces only the reduction of awareness.

The real problem is that psychiatrists fraudulently diagnose life’s problems as an “illness” and stigmatize unwanted stimulus-response behavior as “disease,” using the psychiatric billing bible the DSM as their justification. The bottom line is that all psychiatric “treatments” are harmful.

Psychiatrists will tell you that brain damage itself is what causes an apparent improvement in depression symptoms. In fact, in 1942 American psychiatrist Abraham Myerson said: “The reduction of intelligence is an important factor in the curative process. The fact is that some of the very best cures that one gets are in those individuals whom one reduces almost to amentia [feeble-mindedness]”.

Need we really spell out for you that this is contrary to any healing or beneficial effect at all?

What You Can Do

Contact your local, state and federal officials and representatives and urge them to Ban ECT and other forms of psychiatric shock abuse.

Posted in Big Muddy River Newsletter | Tagged | Leave a comment